Global DNA and Gene Chip Market 2010 – 2015


Posted January 21, 2014 by mnmrahulsan

DNA microarray is the largest contributing segment of the biochip family. DNA microarrays studied in this report are categorized by cDNA (complementary DNA) and oDNA (oligonucleotide DNA), of which oDNA account for as high as 98% of the total market.

 
Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of 13.4%. Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), and others.

New product launches and agreements and collaborations are the two main strategies adopted by the players to stay competitive in this market. Although gene expression has been the dominant application of these chips, cancer diagnostics and treatment will lead the market in 2015 with a share of 24.2% as more and more companies invest in diagnostic chips since early detection of the disease and targeted treatment options are still the unmet need of this market. There were 12.3 million new cases of cancer worldwide in 2007 and about 7.6 million deaths. These figures are estimated to rise up to 16 million new cancer diagnoses cases and about 10 million deaths by 2020 according to WHO & American Cancer Society.

Scope of the report:

This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of applications:

Gene Expression, cancer diagnostics & treatments, drug discovery, genetics (DNA sequencing by hybridization, reverse genetics, functional genomics and genomic mismatch scanning, gene mapping, diagnosis), SNP analysis, screening & monitoring of patient data during clinical trials, proteomics, toxicogenomics, microbial genotyping, agricultural biology, and environmental control.

On the basis of types:

Oligonucleotide DNA Microarrays (oDNA) and Complementary DNA Microarrays (cDNA)

On the basis of geography:

North America, Europe, Asia, and Rest of the World

About MarketsandMarkets:
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Rahul Sankrityayan
Website Markets and Markets
Country United States
Categories Biotech
Tags dn amarket , gene chip market , genechips market
Last Updated January 21, 2014